UNICA IRIS Institutional Research Information System

COLLU, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 26.011
NA - Nord America 1.899
AS - Asia 607
SA - Sud America 99
AF - Africa 9
Totale 28.625
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 25.604
US - Stati Uniti d'America 1.875
CN - Cina 245
SG - Singapore 238
UA - Ucraina 120
SE - Svezia 100
BR - Brasile 85
DE - Germania 60
VN - Vietnam 35
FI - Finlandia 33
KR - Corea 33
GB - Regno Unito 28
FR - Francia 21
CA - Canada 13
IN - India 13
HK - Hong Kong 9
BE - Belgio 8
MX - Messico 7
AE - Emirati Arabi Uniti 6
BD - Bangladesh 6
ES - Italia 6
AT - Austria 5
MA - Marocco 5
PL - Polonia 5
EC - Ecuador 4
IQ - Iraq 4
RU - Federazione Russa 4
AR - Argentina 3
BG - Bulgaria 3
CO - Colombia 3
JP - Giappone 3
LT - Lituania 3
NL - Olanda 3
SA - Arabia Saudita 3
DO - Repubblica Dominicana 2
ID - Indonesia 2
IE - Irlanda 2
IR - Iran 2
LV - Lettonia 2
UY - Uruguay 2
VE - Venezuela 2
ZA - Sudafrica 2
AO - Angola 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
PA - Panama 1
RO - Romania 1
TM - Turkmenistan 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 28.625
Salva come PNG Salva come JPEG
Città #
Cagliari 25.064
Uta 462
Fairfield 221
Woodbridge 179
Ashburn 167
Houston 152
Chandler 133
Singapore 105
Ann Arbor 96
Wilmington 89
Seattle 85
Dallas 81
Jacksonville 74
Nyköping 74
Cambridge 73
Boardman 62
Dearborn 48
Beijing 46
Shanghai 30
Nanjing 26
Seoul 25
Los Angeles 23
Santa Clara 23
The Dalles 23
Helsinki 16
Boston 14
New York 14
San Diego 12
Buffalo 11
Hefei 10
Ho Chi Minh City 10
São Paulo 10
Hanoi 9
Hong Kong 9
Brussels 8
Kunming 8
Changsha 7
Shenyang 7
Atlanta 6
Frankfurt am Main 6
Munich 6
Nanchang 6
Casablanca 5
Chennai 5
Guangzhou 5
Hebei 5
Stockholm 5
Toronto 5
Warsaw 5
Denver 4
Dong Ket 4
Gonnosfanàdiga 4
Jiaxing 4
Lauterbourg 4
Mountain View 4
Nürnberg 4
Sassari 4
Taizhou 4
Washington 4
Alvorada 3
Brooklyn 3
Calgary 3
Campinas 3
Chicago 3
Da Nang 3
Detroit 3
Dhaka 3
Dubai 3
Düsseldorf 3
Edinburgh 3
Fuzhou 3
Guayaquil 3
Jeddah 3
Jinan 3
London 3
Milan 3
Mumbai 3
Phoenix 3
Piscataway 3
Porto Alegre 3
Redwood City 3
Shenzhen 3
Tokyo 3
Vienna 3
Auburn Hills 2
Bauru 2
Bengaluru 2
Biên Hòa 2
Columbus 2
Council Bluffs 2
Guarulhos 2
Hangzhou 2
Jakarta 2
Johannesburg 2
Manchester 2
Montevideo 2
Montreal 2
Ninh Bình 2
Nuremberg 2
Oklahoma City 2
Totale 27.712
Salva come PNG Salva come JPEG
Nome #
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 2.840
N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: A novel class of anti-RSV agents 2.616
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents 2.611
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems 2.375
Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation. 1.966
Design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol -4-yl-methylaniline derivatives. 1.864
Aryl nucleoside H-phosphonates. Part 15: Synthesis, properties and, anti-HIV activity of aryl nucleoside 50-a-hydroxyphosphonates 1.224
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives 1.200
null 950
null 896
null 895
null 857
null 833
null 832
Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives 788
null 786
null 760
null 717
null 694
null 505
Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors 387
Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors 300
Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitors 284
Synthesis and anti-HIV-1 evaluation of 1,5-disubstituted pyrimidine-2,4-diones 261
Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 240
Synthesis and anti-Picornaviridae in vitro activity of a new class of helicase inhibitors the N,N’-bis[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkyldicarboxamides 217
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate 216
Design, synthesis and anti Flaviviridae activity of N6-, 5’,3’-O- and 5’,2’-O-substituted adenine nucleoside analogs 206
Synthesis of variously substituted 3-phenoxymethyl quinoxalin-2-ones and quinoxalines capable to potenziate in vitro the antiproliferative activity of anticancer drugs in multi-drug resistant cell lines 199
4-Substituted anilino imidazo[1,2-a] and triazolo[4,3-a]quinoxalines. Synthesis and evaluation of in vitro biological activity 193
Totale 28.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.003 0 0 0 0 0 688 367 330 89 253 180 96
2021/20221.481 162 143 52 77 125 147 85 93 133 101 164 199
2022/20232.014 226 272 218 137 180 221 108 97 132 138 189 96
2023/20242.100 76 100 99 127 218 322 353 164 95 129 204 213
2024/20252.866 419 576 417 373 241 238 357 21 77 48 47 52
2025/2026726 96 79 153 142 149 107 0 0 0 0 0 0
Totale 28.712